{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:38:33Z","timestamp":1793752713448,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA269231"],"award-info":[{"award-number":["R01CA269231"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10015-5","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T06:01:30Z","timestamp":1691215290000},"page":"643-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of diffusion-weighted MRI and [18F]FDG PET\/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Wipawee","family":"Morakote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Baratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakthi K.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir H.","family":"Sarrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-819X","authenticated-orcid":false,"given":"Heike E.","family":"Daldrup-Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"key":"10015_CR1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","volume":"33","author":"JT Sandlund","year":"2015","unstructured":"Sandlund JT, Guillerman RP, Perkins SL et al (2015) International pediatric non-Hodgkin lymphoma response criteria. J Clin Oncol 33:2106\u20132111","journal-title":"J Clin Oncol"},{"key":"10015_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","volume":"37","author":"R Riad","year":"2010","unstructured":"Riad R, Omar W, Kotb M et al (2010) Role of PET\/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging 37:319\u2013329","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10015_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.10.4923","volume":"195","author":"MC Adams","year":"2010","unstructured":"Adams MC, Turkington TG, Wilson JM, Wong TZ (2010) A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 195:310\u2013320","journal-title":"AJR Am J Roentgenol"},{"key":"10015_CR4","first-page":"4464","volume":"91","author":"W R\u00f6mer","year":"1998","unstructured":"R\u00f6mer W, Hanauske AR, Ziegler S et al (1998) Positron emission tomography in non-Hodgkin\u2019s lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 91:4464\u20134471","journal-title":"Blood"},{"key":"10015_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2214\/AJR.15.15083","volume":"206","author":"AC Sher","year":"2016","unstructured":"Sher AC, Seghers V, Paldino MJ et al (2016) Assessment of sequential PET\/MRI in comparison with PET\/CT of pediatric lymphoma: a prospective study. AJR Am J Roentgenol 206:623\u2013631","journal-title":"AJR Am J Roentgenol"},{"key":"10015_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11307-017-1105-7","volume":"20","author":"AM Muehe","year":"2018","unstructured":"Muehe AM, Theruvath AJ, Lai L et al (2018) How to provide gadolinium-free PET\/MR cancer staging of children and young adults in less than 1 h: the Stanford approach. Mol Imaging Biol 20:324\u2013335","journal-title":"Mol Imaging Biol"},{"key":"10015_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1148\/radiol.14131732","volume":"273","author":"JF Sch\u00e4fer","year":"2014","unstructured":"Sch\u00e4fer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET\/MR imaging in comparison to PET\/CT in pediatric oncology: initial results. Radiology 273:220\u2013231","journal-title":"Radiology"},{"key":"10015_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00247-012-2570-4","volume":"43","author":"FW Hirsch","year":"2013","unstructured":"Hirsch FW, Sattler B, Sorge I et al (2013) PET\/MR in children. Initial clinical experience in paediatric oncology using an integrated PET\/MR scanner. Pediatr Radiol 43:860\u2013875","journal-title":"Pediatr Radiol"},{"key":"10015_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1258\/ar.2010.100246","volume":"52","author":"G Abdulqadhr","year":"2011","unstructured":"Abdulqadhr G, Molin D, Astr\u00f6m G et al (2011) Whole-body diffusion-weighted imaging compared with FDG-PET\/CT in staging of lymphoma patients. Acta Radiol 52:173\u2013180","journal-title":"Acta Radiol"},{"key":"10015_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1593\/neo.81328","volume":"11","author":"AR Padhani","year":"2009","unstructured":"Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102\u2013125","journal-title":"Neoplasia"},{"key":"10015_CR11","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s00330-007-0588-z","volume":"17","author":"M Sumi","year":"2007","unstructured":"Sumi M, Ichikawa Y, Nakamura T (2007) Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol 17:2631\u20132637","journal-title":"Eur Radiol"},{"key":"10015_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0720-048X(02)00310-8","volume":"45","author":"AM Herneth","year":"2003","unstructured":"Herneth AM, Guccione S, Bednarski M (2003) Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 45:208\u2013213","journal-title":"Eur J Radiol"},{"key":"10015_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/RLU.0000000000001344","volume":"42","author":"A Afaq","year":"2017","unstructured":"Afaq A, Fraioli F, Sidhu H et al (2017) Comparison of PET\/MRI with PET\/CT in the evaluation of disease status in lymphoma. Clin Nucl Med 42:e1\u2013e7","journal-title":"Clin Nucl Med"},{"key":"10015_CR14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/jmri.25884","volume":"47","author":"C Giraudo","year":"2018","unstructured":"Giraudo C, Karanikas G, Weber M et al (2018) Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging. J Magn Reson Imaging 47:1217\u20131226","journal-title":"J Magn Reson Imaging"},{"key":"10015_CR15","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00261-016-0638-6","volume":"41","author":"W Atkinson","year":"2016","unstructured":"Atkinson W, Catana C, Abramson JS et al (2016) Hybrid FDG-PET\/MR compared to FDG-PET\/CT in adult lymphoma patients. Abdom Radiol (NY) 41:1338\u20131348","journal-title":"Abdom Radiol (NY)"},{"key":"10015_CR16","doi-asserted-by":"publisher","first-page":"e0490","DOI":"10.1097\/MD.0000000000010490","volume":"97","author":"H Bernstine","year":"2018","unstructured":"Bernstine H, Domachevsky L, Nidam M et al (2018) 18F-FDG PET\/MR imaging of lymphoma nodal target lesions: comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC). Medicine (Baltimore) 97:e0490","journal-title":"Medicine (Baltimore)"},{"key":"10015_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/nbm.3105","volume":"27","author":"MJ Siegel","year":"2014","unstructured":"Siegel MJ, Jokerst CE, Rajderkar D et al (2014) Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: a pilot study. NMR Biomed 27:681\u2013691","journal-title":"NMR Biomed"},{"key":"10015_CR18","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-14-2454","volume":"21","author":"ME Mayerhoefer","year":"2015","unstructured":"Mayerhoefer ME, Karanikas G, Kletter K et al (2015) Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET\/CT-controlled prospective study in 64 patients. Clin Cancer Res 21:2506\u20132513","journal-title":"Clin Cancer Res"},{"key":"10015_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1148\/radiol.2020192508","volume":"296","author":"AJ Theruvath","year":"2020","unstructured":"Theruvath AJ, Siedek F, Muehe AM et al (2020) Therapy response assessment of pediatric tumors with whole-body diffusion-weighted MRI and FDG PET\/MRI. Radiology 296:143\u2013151","journal-title":"Radiology"},{"key":"10015_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0284185114526087","volume":"56","author":"T Hagtvedt","year":"2015","unstructured":"Hagtvedt T, Seierstad T, Lund KV et al (2015) Diffusion-weighted MRI compared to FDG PET\/CT for assessment of early treatment response in lymphoma. Acta Radiol 56:152\u2013158","journal-title":"Acta Radiol"},{"key":"10015_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00330-018-5445-8","volume":"29","author":"A Latifoltojar","year":"2019","unstructured":"Latifoltojar A, Punwani S, Lopes A et al (2019) Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin\u2019s lymphoma: a comparison with multi-modality reference standard including (18)F-FDG-PET-CT. Eur Radiol 29:202\u2013212","journal-title":"Eur Radiol"},{"key":"10015_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0846537119888380","volume":"71","author":"G Shapira-Zaltsberg","year":"2020","unstructured":"Shapira-Zaltsberg G, Wilson N, Trejo Perez E et al (2020) Whole-body diffusion-weighted MRI compared to (18 F)FDG PET\/CT in initial staging and therapy response assessment of Hodgkin lymphoma in pediatric patients. Can Assoc Radiol J 71:217\u2013225","journal-title":"Can Assoc Radiol J"},{"key":"10015_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00259-018-3937-z","volume":"45","author":"ME Mayerhoefer","year":"2018","unstructured":"Mayerhoefer ME, Raderer M, Jaeger U et al (2018) Ultra-early response assessment in lymphoma treatment: [(18)F]FDG PET\/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment. Eur J Nucl Med Mol Imaging 45:931\u2013940","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10015_CR24","unstructured":"Lymphoma: regional lymph nodes, National Cancer Institute, SEER training module. Available via https:\/\/training.seer.cancer.gov\/lymphoma\/anatomy\/lymph-nodes.html. Accessed 8 Jun 2023"},{"key":"10015_CR25","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"10015_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/RLI.0b013e3182087b03","volume":"46","author":"C Lin","year":"2011","unstructured":"Lin C, Itti E, Luciani A et al (2011) Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 46:341\u2013349","journal-title":"Invest Radiol"},{"key":"10015_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(14)70021-X","volume":"15","author":"C Klenk","year":"2014","unstructured":"Klenk C, Gawande R, Uslu L et al (2014) Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET\/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. Lancet Oncol 15:275\u2013285","journal-title":"Lancet Oncol"},{"key":"10015_CR28","doi-asserted-by":"publisher","first-page":"e200061","DOI":"10.1148\/rycan.2021200061","volume":"3","author":"KN De Paepe","year":"2021","unstructured":"De Paepe KN, Van Keerberghen CA, Agazzi GM et al (2021) Quantitative whole-body diffusion-weighted MRI after one treatment cycle for aggressive non-Hodgkin lymphoma is an independent prognostic factor of outcome. Radiol Imaging Cancer 3:e200061","journal-title":"Radiol Imaging Cancer"},{"key":"10015_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11547-015-0581-6","volume":"121","author":"N Maggialetti","year":"2016","unstructured":"Maggialetti N, Ferrari C, Minoia C et al (2016) Role of WB-MR\/DWIBS compared to 18F-FDG PET\/CT in the therapy response assessment of lymphoma. Radiol Med (Torino) 121:132\u2013143","journal-title":"Radiol Med (Torino)"},{"key":"10015_CR30","doi-asserted-by":"publisher","first-page":"8925","DOI":"10.1007\/s00330-021-08026-1","volume":"31","author":"S Spijkers","year":"2021","unstructured":"Spijkers S, Littooij AS, Kwee TC et al (2021) Whole-body MRI versus an [(18)F]FDG-PET\/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin\u2019s lymphoma: a prospective multicentre study. Eur Radiol 31:8925\u20138936","journal-title":"Eur Radiol"},{"key":"10015_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1001-9294(09)60033-X","volume":"23","author":"HD Xue","year":"2008","unstructured":"Xue HD, Li S, Sun HY, Jin ZY, Sun F (2008) Experimental study of inflammatory and metastatic lymph nodes with diffusion weighted imaging on animal model: comparison with conventional methods. Chin Med Sci J 23:166\u2013171","journal-title":"Chin Med Sci J"},{"key":"10015_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MNM.0b013e328334fc14","volume":"31","author":"R Riad","year":"2010","unstructured":"Riad R, Omar W, Sidhom I et al (2010) False-positive F-18 FDG uptake in PET\/CT studies in pediatric patients with abdominal Burkitt\u2019s lymphoma. Nucl Med Commun 31:232\u2013238","journal-title":"Nucl Med Commun"},{"key":"10015_CR33","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1200\/JCO.2009.26.5942","volume":"28","author":"CH Moskowitz","year":"2010","unstructured":"Moskowitz CH, Sch\u00f6der H, Teruya-Feldstein J et al (2010) Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma. J Clin Oncol 28:1896\u20131903","journal-title":"J Clin Oncol"},{"key":"10015_CR34","first-page":"54","volume":"1","author":"C Bailly","year":"2014","unstructured":"Bailly C, Eug\u00e8ne T, Couec ML et al (2014) Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med (Lausanne) 1:54","journal-title":"Front Med (Lausanne)"},{"key":"10015_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1102\/1470-7330.2013.0006","volume":"13","author":"K De Paepe","year":"2013","unstructured":"De Paepe K, Bevernage C, De Keyzer F et al (2013) Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study. Cancer Imaging 13:53\u201362","journal-title":"Cancer Imaging"},{"key":"10015_CR36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/jmri.24714","volume":"41","author":"K Tsuji","year":"2015","unstructured":"Tsuji K, Kishi S, Tsuchida T et al (2015) Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: a comparison with FDG-PET\/CT. J Magn Reson Imaging 41:1601\u20131607","journal-title":"J Magn Reson Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10015-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10015-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10015-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:10:09Z","timestamp":1705425009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10015-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10015"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10015-5","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Heike E. Daldrup-Link, MD, PhD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"All patients or their legally authorized representative signed a written informed consent, and all children between 7 and 18\u00a0years of age signed an assent form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained (IRB-44706).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"There is no overlap with previously published work.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}